The Recall Desk

Manufacturer

Shire Human Genetic Therapies, Inc.

5 recalls in our database name Shire Human Genetic Therapies, Inc. as the manufacturing or recalling firm.

What the numbers show

Total
5
Critical
3
Severe
2
Most recent
2019-10-02

Of the 5 recalls from Shire Human Genetic Therapies, Inc. we have scored against our rubric, 3 (60%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2 (40%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–5 of 5

  • CriticalFDA (Drugs)·D-0038-2020·2019-10-02

    Natpara Injection Recall Issued for Potential Needle Clogging and Underdosing

    Shire is recalling Natpara (parathyroid hormone) for Injection due to a defective delivery system that may allow rubber stopper particles to clog the needle, leading to underdosing.

    Product
    Natpara (parathyroid hormone) for Injection, 100 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA 68875-0205-02
    Category
    Drug
    Distribution
    0 states
  • CriticalFDA (Drugs)·D-0036-2020·2019-10-02

    Natpara Injection Cartridges Recalled for Potential Needle Clogging

    Shire is recalling Natpara injection cartridges because rubber stopper particles may clog the needle, potentially causing underdosing.

    Product
    Natpara (parathyroid hormone) for Injection, 50 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0203-02
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0037-2020·2019-10-02

    Natpara Injection Cartridges Recalled for Potential Needle Clogging

    Shire is recalling Natpara (parathyroid hormone) injection cartridges because rubber stopper particles may clog the needle, leading to underdosing.

    Product
    Natpara (parathyroid hormone) for Injection, 75 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0204-02
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0035-2020·2019-10-02

    Natpara Injection Recall Due to Potential Needle Clogging and Underdosing

    Shire is recalling Natpara (parathyroid hormone) injections because rubber stopper particles may clog the needle, potentially causing underdosing.

    Product
    Natpara (parathyroid hormone) for Injection, 25 mcg/dose, 2 pack cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0202-02
    Category
    Drug
    Distribution
    0 states
  • CriticalFDA (Drugs)·D-1251-2014·2014-04-30

    Shire Recalls VPRIV Vials Due to Presence of Particulate Matter

    Shire Human Genetic Therapies is recalling 8,359 vials of VPRIV (velaglucerase alfa) because they contain stainless steel and barium sulfate particles.

    Product
    VPRIV — VPRIV (VELAGLUCERASE ALFA)
    Category
    Drug
    Distribution
    Distributed nationwide

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

SHIRE HUMAN GENETIC THERAPIES, INC.

Source: Wikidata (Q140196010), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.